MedPath

Philipp Schütz

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO)

Not Applicable
Not yet recruiting
Conditions
Malnutrition
Interventions
Drug: Placebo
First Posted Date
2025-02-13
Last Posted Date
2025-02-13
Lead Sponsor
Philipp Schuetz
Target Recruit Count
20
Registration Number
NCT06826105
Locations
🇨🇭

Kantonsspital Aarau, Aarau, Switzerland

Effect of Continued Nutritional Support at Hospital Discharge on Mortality, Frailty, Functional Outcomes and Recovery

Not Applicable
Recruiting
Conditions
Malnutrition
First Posted Date
2021-06-15
Last Posted Date
2024-11-20
Lead Sponsor
Philipp Schuetz
Target Recruit Count
1200
Registration Number
NCT04926597
Locations
🇪🇸

Hospital Universitari Vall Hebron de Barcelona, Barcelona, Spain

🇪🇸

Hospital Universitario de Getafe, Getafe, Spain

🇪🇸

Complejo AComplejo Asistencial Universitario de León, León, Spain

and more 15 locations

Technical Evaluation of Brahms PCT Direct

Completed
Conditions
Infection
First Posted Date
2013-01-18
Last Posted Date
2014-12-12
Lead Sponsor
Philipp Schuetz
Target Recruit Count
150
Registration Number
NCT01771029
Locations
🇫🇷

Pitié Salpetrière. Groupement hospitalière universitaire Est, Paris, France

🇩🇪

Klinikum Ernst von Bergmann, gemeinnützige GmbH Akademisches Lehrkrankenhaus der Humboldt-Universität Berlin (Charité), Potsdam, Germany

🇨🇭

Kantonsspital Aarau Innere Medizin, Aarau, Aargau, Switzerland

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.